All Stories

  1. In Vitro Susceptibility and Molecular Docking of Echinocandins Against Clinical Dermatophyte Isolates: Implications for Resistant Dermatophytosis
  2. Correction to Lancet Neurol 2026; 25: 451–68
  3. Isolation of a multidrug-resistant Candida auris Clade V from an asymptomatic acute myeloid leukemia patient in the intensive care unit
  4. Global burden of enteric infectious diseases, diarrhoeal diseases, and corresponding aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
  5. Efficacy Evaluation of Luliconazole‐Loaded Nanostructured Lipid Carriers in Treatment‐Resistant Dermatophytosis: A Randomized Clinical Trial
  6. Correction to Lancet Infect Dis 2026; published online June 2. https://doi.org/10.1016/S1473-3099(26)00194-5
  7. Correction to Lancet Infect Dis 2026; 26: 343–61
  8. Oral Cryptococcosis due to Naganishia diffluens in a Patient With Thalassemia: A Case Report and a Literature Review
  9. Correction to Lancet Infect Dis 2026; 26: 343–61
  10. A deep dive into the diversity of the Aspergillus community in the lakes of northern Iran
  11. Meningitis around the world: 17 germs, 259,000 deaths and the road to 2030
  12. Acknowledging our reviewers
  13. Assessment of skin yeast colonization and its predisposing factors among neonates admitted to the neonatal intensive care unit
  14. Reviewer Thank You List 2025
  15. Global, regional, and national sepsis incidence and mortality, 1990–2021: a systematic analysis
  16. Reviewer Thank You List 2025
  17. Design and immunological evaluation of a multi-epitope vaccine candidate against Toxoplasma gondii incorporating MIC13, GRA1, and SAG1 antigens in BALB/c mice
  18. Insights into Persian Gulf Beach Sand Mycobiomes: Promises and Challenges in Fungal Diversity
  19. Molecular epidemiology, diversity, and antifungal susceptibility profiles of clinical and environmental mucorales: a five-year multicenter study in Iran (2018–2023)
  20. Pathogenicity Evaluation on Fluconazole-Resistant Candida auris Clade V in Murine Model
  21. A fatal post-COVID-19 sino-orbital mucormycosis in an adult patient with diabetes mellitus: a case report and review of the literature
  22. Deciphering Fluconazole Resistance in Candida auris clade V: The Role of Efflux Pump Gene Expression and Ergosterol Pathway Mutations
  23. Characterization of COVID‐19‐Associated Candidemia Among Burn Patients
  24. A Novel Niosomal Gel for Topical Delivery of Miltefosine Against Trichophyton indotineae Dermatophytosis in Animal Model
  25. Acknowledging our reviewers
  26. Acknowledgement to Reviewers
  27. Genetic diversity and antibiotic resistance patterns of Escherichia coli isolates causing septicemia: A phylogenetic typing and PFGE analysis
  28. Reviewer acknowledgment 2024
  29. Prevalence of Fungal Infections in Pemphigus Patients: A Systematic Review and Meta‐Analysis
  30. Reviewer Acknowledgement 2024
  31. Reviewer Thank You List 2024
  32. An Unusual High Prevalence of Cryptococcus (Naganishia) diffluens Colonization in Neonates Hospitalized in a Referral Neonatal Intensive Care Unit
  33. Multi‐state evaluation of Candida infections in burn patients
  34. Metabolic Patterns of Fluconazole Resistant and Susceptible Candida auris Clade V and I
  35. High Prevalence of Terbinafine Resistance Among Trichophyton mentagrophytes/T. interdigitale Species Complex, a Cross-Sectional Study from 2021 to 2022 in Northern Parts of Iran
  36. Molecular Epidemiology and Antifungal Susceptibility Profile in Nakaseomyces glabrata Species Complex: A 5‐Year Countrywide Study
  37. Editorial Board
  38. Molecular typing of a collection of Iranian clinical Trichophyton tonsurans isolates based on the non‐transcribed spacer region of rDNA and antifungal susceptibility testing of the species
  39. Central nervous system Aspergillus quadrilineatus infection in a COVID‐19 patient, a case report and literature review
  40. Onychomycosis due to Fusarium species in different continents, literature review on diagnosis and treatment
  41. Investigating intestinal parasitic infections with emphasis on molecular identification of Strongyloides stercoralis and Trichostrongylus colubriformis in north of Iran
  42. Potential Inhibitory Effect of Miltefosine against Terbinafine-Resistant Trichophyton indotineae
  43. Antifungal activity of miltefosine against both azole-susceptible and -resistant Aspergillus strains
  44. Antifungal Resistance of Clinical Candida albicans Isolates in Iran: A Systematic Review and Meta-Analysis
  45. Acknowledgment to the Reviewers of Journal of Fungi in 2022
  46. Acknowledgment to the Reviewers of Diagnostics in 2022
  47. Acknowledgment to the Reviewers of Antibiotics in 2022
  48. Acknowledgment to the Reviewers of Life in 2022
  49. Enhancement of immune responses by vaccine potential of three antigens, including ROP18, MIC4, and SAG1 against acute toxoplasmosis in mice
  50. In vitro antifungal susceptibility profile of Iranian Fusarium isolates: Emphasising on the potent inhibitory effect of efinaconazole compared to other drugs
  51. 2022 OFID Reviewer Recognition List
  52. A new record of Scedosporium dehoogii isolated from paddy field soil in Iran: Phylogeny and antifungal susceptibility profiles
  53. First report of tinea corporis caused by Trichophyton quinckeanum in Iran and its antifungal susceptibility profile
  54. In Vitro Combination of Terbinafine with Ketoconazole Against Aspergillus Species with Terbinafine High MIC Values Isolated From Otomycosis
  55. Identification and multilocus genotyping of Toxoplasma gondii isolates from congenital infection in north of Iran
  56. P055 Antifungal resistance of clinical Candida albicans isolates in Iran: asystematic review and meta-analysis
  57. P285 Predominance of Trichophyton tonsurans causing tinea capitis: a 12-years retrospective study in north of Iran
  58. Post-antifungal effect of the combination of anidulafungin with amphotericin B and fluconazole against fluconazole-susceptible and -resistant Candida albicans
  59. Iranian National Survey on Tinea Capitis: Antifungal Susceptibility Profile, Epidemiological Characteristics, and Report of Two Strains with a Novel Mutation in SQLE Gene with Homology Modeling
  60. Genetic characterization of Toxoplasma gondii in meat-producing animals in Iran
  61. In vitro activity of 23 antifungal drugs against 54 clinical and environmental Aspergillus oryzae isolates
  62. Mass spectrometry in research laboratories and clinical diagnostic: a new era in medical mycology
  63. Otomycosis in the South of Iran with a High Prevalence of Tympanic Membrane Perforation: A Hospital-Based Study
  64. 2021 OFID Reviewer Recognition List
  65. Antifungal Properties of Zataria multiflora on Candida species: A Systematic Review
  66. Acknowledgment of Reviewers 2021
  67. Acknowledgment of Reviewers 2021
  68. In Vitro Antifungal Activity of Luliconazole, Efinaconazole, and Nine Comparators Against Aspergillus and Candida Strains Isolated from Otomycosis
  69. Molecular identification and antifungal susceptibility profiles of Candida dubliniensis and Candida africana isolated from vulvovaginal candidiasis: A single‐center experience in Iran
  70. Protective efficacy by a novel multi-epitope vaccine, including MIC3, ROP8, and SAG1, against acute Toxoplasma gondii infection in BALB/c mice
  71. Molecular Identification and Antifungal Susceptibility of Yeasts and Molds Isolated from Patients with Otomycosis
  72. Familial Cases of Trichophyton benhamiae Infection Transmitted from a Guinea Pig in Iran
  73. Toxoplasmosis among cancer patients undergoing chemotherapy: a population study based on the serological, molecular and epidemiological aspects
  74. In vitro activities of antifungal drugs against a large collection of Trichophyton tonsurans isolated from wrestlers
  75. Relationship between blood group and risk of infection and death in COVID-19: a live meta-analysis
  76. Candida africana vulvovaginitis: Prevalence and geographical distribution
  77. Relationship Between Blood Group and Risk of Infection and Death in COVID-19: a live Meta-Analysis
  78. Cryptococcus and cryptococcosis in Iran during 1969–2019: A systematic review and meta-analysis
  79. Antifungal Activity of a Novel Triazole, Efinaconazole and Nine Comparators against 354 Molecularly Identified Aspergillus Isolates
  80. The global serological prevalence of Toxoplasma gondii in felids during the last five decades (1967–2017): a systematic review and meta-analysis
  81. Cover Image
  82. In vitro activities of 15 antifungal drugs against a large collection of clinical isolates of Microsporum canis
  83. A systematic review of Toxoplasma gondii genotypes and feline: Geographical distribution trends
  84. Emerging Candida species isolated from renal transplant recipients: Species distribution and susceptibility profiles
  85. Molecular epidemiology of environmental Cryptococcus species isolates based on amplified fragment length polymorphism
  86. Human toxoplasmosis: a systematic review for genetic diversity of Toxoplasma gondii in clinical samples
  87. Pesticide behavior in paddy fields and development of azole-resistant Aspergillus fumigatus : Should we be concerned?
  88. Cerebral phaeohyphomycosis due to Rhinocladiella mackenziei in Persian Gulf region: A case and review
  89. <i>Toxoplasma gondii</i> Genotypes and Feline: Geographical Distribution Trends